Find a Commonwealth Resource
Rizatriptan benzoate
HealthData.Gov
Updated Oct 29, 2026
About this dataset
Rizatriptan Benzoate is a generic prescription drug used to treat migraine headaches. It comes as orally disintegrating tablets in 5 mg and 10 mg strengths, taken by mouth. Manufactured by Glenmark Pharmaceuticals Inc., USA, under application ANDA201914, it is now discontinued. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Rizatriptan benzoate
Access the FDA dataset for Rizatriptan benzoate — ANDA 204339 submitted by Mylan Institutional LLC
Modified Aug 29, 2026